Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

Author： Dayan Gustavo H.   Pugachev Konstantin   Bevilacqua Joan   Lang Jean   Monath Thomas P.  

Publisher： MDPI

E-ISSN： 1999-4915|5|12|3048-3070

ISSN： 1999-4915

Source： Viruses, Vol.5, Iss.12, 2013-12, pp. : 3048-3070

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vaccines in Development against West Nile Virus

By Brandler Samantha   Tangy Frederic  

Viruses, Vol. 5, Iss. 10, 2013-09 ,pp. : 2384-2409

MDPI

Access to resources Recommend Favorite

Clinical Manifestations and Outcomes of West Nile Virus Infection

By Sejvar James J.  

Viruses, Vol. 6, Iss. 2, 2014-02 ,pp. : 606-623

MDPI

Access to resources Recommend Favorite

West Nile Virus Drug Discovery

By Lim Siew Pheng   Shi Pei-Yong  

Viruses, Vol. 5, Iss. 12, 2013-12 ,pp. : 2977-3006

MDPI

Access to resources Recommend Favorite

Infection with Non-Lethal West Nile Virus Eg101 Strain Induces Immunity that Protects Mice against the Lethal West Nile Virus NY99 Strain

By Kumar Mukesh   O’Connell Maile   Namekar Madhuri   Nerurkar Vivek R.  

Viruses, Vol. 6, Iss. 6, 2014-06 ,pp. : 2328-2339

MDPI

Access to resources Recommend Favorite

West Nile Virus in the United States — A Historical Perspective

By Roehrig John T.  

Viruses, Vol. 5, Iss. 12, 2013-12 ,pp. : 3088-3108

MDPI

Access to resources Recommend Favorite